Delivery Order SPE2DX22D0049-SPE2D826FA2NP
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,605.70 to AmerisourceBergen Drug Corp on December 11, 2025, for pharmaceutical and medical supply products. This firm fixed-price, non-competitive delivery order is set to conclude on December 12, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $134,890.92 to AmerisourceBergen Drug Corp on December 15, 2025, with an ultimate completion date of December 16, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to be delivered to Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $45,459.70 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,752.42 to AmerisourceBergen Drug Corp on December 11, 2025, for pharmaceutical and medical supply delivery to support federal healthcare operations. This firm fixed-price, non-set-aside delivery order is scheduled for completion by December 12, 2025, with performance at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $110,752.60 to AmerisourceBergen Drug Corp on December 6, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. The contract was performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $141,513 to AmerisourceBergen Drug Corp on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,909.80 to AmerisourceBergen Drug Corp on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $67,680.98 to AmerisourceBergen Drug Corp on November 6, 2025, for pharmaceutical and medical supply products. This competitively awarded, firm fixed-price delivery order is not set-aside and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $23,250.10 to AmerisourceBergen Drug Corp on December 8, 2025, for pharmaceutical and medical supply products. This non-set-aside, competitively awarded contract is structured as a firm fixed-price delivery order with a completion date of December 9, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,646.95 to AmerisourceBergen Drug Corp on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies supporting federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA2NPDelivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $141,154.56 to AmerisourceBergen Drug Corp on December 15, 2025, for pharmaceutical and medical supply deliveries. This firm fixed-price delivery order, which is not set-aside and is competitively awarded, represents performance through December 16, 2025, and will be fulfilled at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor supplying comprehensive pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The broader IDC serves as a global pharmaceutical support vehicle enabling the contractor to supply a vast range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The DLA Troop Support Medical is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen Drug Corp among the key providers serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $141.2k | 12/14/25 |